Cox, Ingrid A. http://orcid.org/0000-0001-5130-4088
de Graaff, Barbara
Ahmed, Hasnat
Campbell, Julie
Otahal, Petr
Corte, Tamera J.
Glaspole, Ian
Moodley, Yuben
Goh, Nicole
Macansh, Sacha
Walters, E. Haydn
Palmer, Andrew J.
Funding for this research was provided by:
National Health and Medical Research Council (GNT1116371)
Boehringer Ingelheim
Galapagos
Roche
Article History
Accepted: 7 May 2021
First Online: 17 May 2021
Declarations
:
: TC reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Roche, grants and personal fees from BMS, personal fees from Promedior, personal fees from Ad Alta, grants from Avalyn Pharma, grants from Biogen, outside the submitted work. IG reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Roche, personal fees from Adalta, personal fees from Accendatech, personal fees from Avalyn Pharma, outside the submitted work; NG reports personal fees from Boehringer-Ingelheim, personal fees from Roche, personal fees from Astra Zeneca, non-financial support from Air Liquide, grants from Lung Foundation Australia, outside the submitted work. All other authors declare that they have no financial/competing interests.
: All study procedures were approved by the University of Tasmania Human Research Ethics Committee (H0016914), Sydney Local Health District, Royal Prince Alfred Zone (Protocol Number X18-0192, Project Number HREC/18/RPAH/269 and SSA/18/RPAH/435), Alfred Health (Site Authorisation Letter 45217) and the Hunter New England Local Health District (SSA/19/HNE/23).
: The authors affirm that signed informed consent was obtained from all individual participants included in this study.
: The authors affirm that individual participants provided informed consent for publication of their data.